Molecular Epidemiology and Pathophysiology of Autoimmune Encephalitis
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (15 July 2022) | Viewed by 26007
Special Issue Editors
Interests: neuro-oncology; brain tumors; cancer genomics; primary central nervous system lymphoma; bioinformatics
Interests: autoimmune encephalitis; neurotoxicity; neurologic paraneoplastic syndrome; peripheral neuropathy; peripheral neurotoxicity
Interests: acute cerebellitis; anti-GAD antibodies; autoimmune cerebellar ataxia; opsoclonus-myoclonus syndrome; neurologic paraneoplastic syndrome
Special Issue Information
Dear Colleagues,
Autoimmune encephalitis encompasses a broad range of diseases with different pathophysiology. Largely due to their rarity and heterogenous nature, these encephalitises are challenging to treat, and frequently recur. Over the last decade, significant progress has been made, providing a better understanding of their physiopathology.
The aim of this Special Issue is to provide a broad overview of the molecular epidemiology and pathophysiological mechanisms that drive autoimmune encephalitis. Overall, the goal is to highlight progress made in preclinical and translational research to improve our understanding of autoimmune encephalitis. We invite both original research and review articles highlighting recent advances in the field of autoimmune encephalitis.
Dr. Agusti Alentorn
Dr. Dimitri Psimaras
Dr. Bastien Joubert
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune encephalitis
- neuronal surface antibody
- antineuronal nuclear antibody
- paraneoplastic syndrome
- limbic encephalitis
- encephalomyelitis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.